As of 2025-02-19, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is (9.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 462.11 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -102.1%.
The range of the Relative Valuation is (44.87) - 43.58 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 21.5x - 29.6x | 25.6x |
Forward P/E multiples | 26.6x - 39.5x | 30.7x |
Fair Price | (44.87) - 43.58 | (9.75) |
Upside | -109.7% - -90.6% | -102.1% |
Date | P/E |
2025-02-18 | -221.65 |
2025-02-14 | -220.16 |
2025-02-13 | -221.88 |
2025-02-12 | -217.38 |
2025-02-11 | -218.35 |
2025-02-10 | -225.42 |
2025-02-07 | -225.11 |
2025-02-06 | -230.79 |
2025-02-05 | -234.28 |
2025-02-04 | -231.33 |
2025-02-03 | -225.61 |
2025-01-31 | -221.44 |
2025-01-30 | -210.28 |
2025-01-29 | -211.77 |
2025-01-28 | -211.37 |
2025-01-27 | -212.91 |
2025-01-24 | -210.86 |
2025-01-23 | -210.92 |
2025-01-22 | -205.29 |
2025-01-21 | -205.24 |
2025-01-17 | -202.41 |
2025-01-16 | -199.99 |
2025-01-15 | -203.50 |
2025-01-14 | -197.45 |
2025-01-13 | -198.27 |
2025-01-10 | -196.45 |
2025-01-08 | -197.67 |
2025-01-07 | -195.85 |
2025-01-06 | -193.05 |
2025-01-03 | -195.27 |
2025-01-02 | -194.62 |
2024-12-31 | -193.15 |
2024-12-30 | -191.55 |
2024-12-27 | -196.06 |
2024-12-26 | -196.97 |
2024-12-24 | -195.78 |
2024-12-23 | -194.39 |
2024-12-20 | -190.55 |
2024-12-19 | -190.25 |
2024-12-18 | -214.64 |
2024-12-17 | -225.07 |
2024-12-16 | -224.52 |
2024-12-13 | -222.43 |
2024-12-12 | -222.61 |
2024-12-11 | -224.61 |
2024-12-10 | -225.06 |
2024-12-09 | -227.34 |
2024-12-06 | -221.65 |
2024-12-05 | -220.60 |
2024-12-04 | -222.55 |